50 Participants Needed

Nitrous Oxide for Aggression

JC
JR
Overseen ByJulian Roberts, R.N.
Age: 18 - 65
Sex: Any
Trial Phase: Phase 2
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

This trial tests if inhaling nitrous oxide can help normalize brain function in people with impulsive aggression. Participants with and without aggressive tendencies will inhale the gas and undergo brain scans to see if it improves their brain activity. The goal is to find a potential treatment for those with Intermittent Explosive Disorder. Nitrous oxide has been shown to reduce involuntary movements in cerebral palsy patients, indicating its potential to affect brain function.

Will I have to stop taking my current medications?

The trial requires participants to be free of antipsychotic medication for two weeks before joining. However, if you are taking SSRIs, SNRIs, or mood stabilizers, you can continue using them as long as you still experience impulsive aggressive behaviors.

What data supports the effectiveness of the drug nitrous oxide for treating aggression?

Nitrous oxide is known for its anesthetic and pain-relieving properties, making it useful in various medical settings. Its ability to be safely administered by trained professionals and even self-administered by patients suggests it could have potential in managing conditions like aggression, although specific studies on aggression are not mentioned.12345

Is nitrous oxide generally safe for human use?

Nitrous oxide is generally considered safe when used in medical settings, like dentistry, for its anesthetic and anti-anxiety effects. However, heavy or prolonged use can lead to vitamin B12 deficiency, causing nerve damage and blood problems. Recreational use can also lead to accidents and, in rare cases, serious health issues.36789

How is nitrous oxide different from other drugs for treating aggression?

Nitrous oxide is unique because it is traditionally used as an anesthetic and for its calming effects in dentistry, but it is now being explored for its potential to treat psychiatric conditions like aggression at lower, non-anesthetic doses. This approach is novel compared to standard treatments, which typically involve medications like antipsychotics or mood stabilizers.13101112

Research Team

EC

Emil Coccaro, Dr

Principal Investigator

Ohio State University

Eligibility Criteria

This trial is for adults aged 21-55 with Intermittent Explosive Disorder (IED) and high aggression scores, but no major psychiatric disorders like psychosis or bipolar disorder, nor current severe substance abuse. Healthy participants without any psychiatric conditions and low aggression can also join.

Inclusion Criteria

Aggressive (IED) Study Participants (n = 25 Completed; 75 Enrolled):
Negative for a history of psychosis, bipolar disorder, developmental disorder, intellectual disability or a current substance use disorder.
I am physically healthy with no significant medical conditions.
See 8 more

Exclusion Criteria

Intellectual disability [i.e., IQ < 70].
History of N2O abuse/dependence.
I have a serious health condition.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
2 visits (in-person)

Treatment

Participants undergo a 60 minute inhalation session with 50% Nitrous Oxide or room air, followed by an fMRI scan 24 hours later

1 week
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
1 visit (in-person)

Treatment Details

Interventions

  • Nitrous Oxide
  • Room Air
Trial OverviewResearchers are testing if inhaling Nitrous Oxide changes brain function in people with impulsive aggression compared to healthy controls. Participants breathe in either Nitrous Oxide or room air for an hour and have a brain scan the next day.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Nitrous Oxide InhalationActive Control1 Intervention
60 minute session inhaling Nitrous Oxide gas.
Group II: Room AirPlacebo Group1 Intervention
60 minute session inhaling Room Air.

Nitrous Oxide is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Nitrous oxide for:
  • Anesthesia
  • Pain relief
  • Hypoxic respiratory failure in neonates
🇺🇸
Approved in United States as Nitrous oxide for:
  • Anesthesia
  • Pain relief
  • Hypoxic respiratory failure in neonates
🇨🇦
Approved in Canada as Nitrous oxide for:
  • Anesthesia
  • Pain relief
  • Hypoxic respiratory failure in neonates

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

Chronic abuse of nitrous oxide (N2O) in pediatric patients can lead to serious neurological issues, including symptoms like limb numbness and weakness, as seen in a study of 9 patients diagnosed with N2O-induced spinal cord degeneration.
Vitamin B12 deficiency was common among these patients, and while all received B12 supplementation and recovered muscle power within 2 months, some experienced lasting sensory deficits, highlighting the importance of prompt treatment to prevent permanent damage.
Recreational nitrous oxide abuse related subacute combined degeneration of the spinal cord in adolescents - A case series and literature review.Lan, SY., Kuo, CY., Chou, CC., et al.[2022]
In a study of 124 children aged 1-17 undergoing procedures in the emergency department, nitrous oxide (N2O) was used for analgesia, but pain scores showed that 34% of patients experienced significant pain (scores of 70 mm or greater) during procedures, indicating limited efficacy for very painful interventions.
Despite the pain management limitations, both parents (96% satisfaction) and staff (92% rated sedation and analgesia as adequate) reported high satisfaction with the use of N2O for procedural sedation in the emergency department.
Limited analgesic efficacy of nitrous oxide for painful procedures in children.Babl, FE., Oakley, E., Puspitadewi, A., et al.[2022]
Two patients developed serious neurological issues, including limb weakness and numbness, after long-term recreational use of nitrous oxide (N2O), leading to a diagnosis of subacute combined degeneration (SCD).
Treatment involved stopping N2O use and administering vitamin B supplements, which significantly improved their symptoms, highlighting the need for awareness of N2O's neurotoxic effects and the importance of early diagnosis to prevent irreversible damage.
Subacute combined degeneration induced by nitrous oxide inhalation: Two case reports.Zhao, B., Zhao, L., Li, Z., et al.[2022]

References

Recreational nitrous oxide abuse related subacute combined degeneration of the spinal cord in adolescents - A case series and literature review. [2022]
Limited analgesic efficacy of nitrous oxide for painful procedures in children. [2022]
Subacute combined degeneration induced by nitrous oxide inhalation: Two case reports. [2022]
Reversible Neuropsychiatric Disturbances Caused by Nitrous Oxide Toxicity: Clinical, Imaging and Electrophysiological Profiles of 21 Patients with 6-12 Months Follow-up. [2022]
Update on nitrous oxide and its use in anesthesia practice. [2019]
Recreational nitrous oxide use: Prevalence and risks. [2022]
Case report of an acute myocardial infarction after high-dose recreational nitrous oxide use: a consequence of hyperhomocysteinaemia? [2022]
[Not Available]. [2019]
Nitrous oxide-induced reproductive risks: Should recreational nitrous oxide users worry? [2022]
10.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry. [2020]
Accidental death by nitrous oxide inhalation. [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
Nitrous oxide "whippit" abuse presenting with cobalamin responsive psychosis. [2021]